Polysaccharide-Based Nanocarriers for Targeted Breast Cancer Treatment

Polysaccharide-based nanoparticles have emerged as versatile nanocarriers for breast cancer therapy, owing to their excellent biocompatibility, biodegradability, low toxicity, and structural versatility. This review summarizes recent advances in the development of polysaccharide-derived nanocarriers, with particular emphasis on their structural characteristics, fabrication strategies, drug delivery mechanisms, therapeutic applications, and translational potential in breast cancer treatment. Major polysaccharides, including chitosan, alginate, dextran, hyaluronic acid, carrageenan, starch, pectin, and pullulan, are discussed with respect to their physicochemical properties, functional modifications, and suitability as drug delivery platforms. Common fabrication approaches, including ionic gelation, polyelectrolyte complexation, nanoprecipitation, emulsion solvent evaporation, green synthesis, and layer-by-layer assembly, are compared in terms of their influence on nanoparticle characteristics, drug loading, stability, and release behavior. This review further highlights key drug delivery mechanisms, including passive targeting via the enhanced permeability and retention (EPR) effect, ligand-mediated active targeting, pH-triggered and enzyme-mediated drug release, and cellular uptake with intracellular trafficking. In addition, topic modeling and academic trend analyses are incorporated to map the evolving research landscape, identify major thematic areas, and highlight shifts in research priorities within the field. Recent therapeutic applications are also discussed, encompassing chemotherapy, gene and small interfering RNA (siRNA) delivery, combination therapy, phototherapy, immunotherapy, and theranostic nanoplatforms. Furthermore, current challenges associated with physicochemical stability, pharmacokinetic behavior, long-term safety, large-scale manufacturing, and regulatory approval are critically evaluated. Collectively, this review highlights the potential of polysaccharide-based nanoparticles as multifunctional platforms for targeted breast cancer therapy and provides perspectives on future strategies to facilitate their successful clinical translation.

Authors

Institutions

Publication Details

Journal
Polymers
Published
2026-11-19
DOI
https://doi.org/10.3390/polym18222906
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Polysaccharide-Based Nanocarriers for Targeted Breast Cancer Treatment

Asif Nawaz, Syed Mahmood, Ebrahim Mahmoudi, Yean Kee Lee et al.
Polymers
Nanoparticle-Based Drug Delivery
article

Polysaccharide-Based Nanocarriers for Targeted Breast Cancer Treatment

Asif Nawaz, Syed Mahmood, Ebrahim Mahmoudi, Yean Kee Lee, Muhammad Luqman Nordin, Fatemeh Gheytasi, Mohammad Reza Maghami
article en

Abstract

Polysaccharide-based nanoparticles have emerged as versatile nanocarriers for breast cancer therapy, owing to their excellent biocompatibility, biodegradability, low toxicity, and structural versatility. This review summarizes recent advances in the development of polysaccharide-derived nanocarriers, with particular emphasis on their structural characteristics, fabrication strategies, drug delivery mechanisms, therapeutic applications, and translational potential in breast cancer treatment. Major polysaccharides, including chitosan, alginate, dextran, hyaluronic acid, carrageenan, starch, pectin, and pullulan, are discussed with respect to their physicochemical properties, functional modifications, and suitability as drug delivery platforms. Common fabrication approaches, including ionic gelation, polyelectrolyte complexation, nanoprecipitation, emulsion solvent evaporation, green synthesis, and layer-by-layer assembly, are compared in terms of their influence on nanoparticle characteristics, drug loading, stability, and release behavior. This review further highlights key drug delivery mechanisms, including passive targeting via the enhanced permeability and retention (EPR) effect, ligand-mediated active targeting, pH-triggered and enzyme-mediated drug release, and cellular uptake with intracellular trafficking. In addition, topic modeling and academic trend analyses are incorporated to map the evolving research landscape, identify major thematic areas, and highlight shifts in research priorities within the field. Recent therapeutic applications are also discussed, encompassing chemotherapy, gene and small interfering RNA (siRNA) delivery, combination therapy, phototherapy, immunotherapy, and theranostic nanoplatforms. Furthermore, current challenges associated with physicochemical stability, pharmacokinetic behavior, long-term safety, large-scale manufacturing, and regulatory approval are critically evaluated. Collectively, this review highlights the potential of polysaccharide-based nanoparticles as multifunctional platforms for targeted breast cancer therapy and provides perspectives on future strategies to facilitate their successful clinical translation.

PolymersVol. 18(22)
Chulalongkorn University (TH), Asia Pacific University of Technology & Innovation (MY), University of Malaya (MY), National University of Malaysia (MY)
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon